Airtasker: So far proving up to the task

About the author:

Anthony Porto
Author name:
By Anthony Porto
Job title:
Senior Analyst
Date posted:
20 August 2021, 7:00 AM
Sectors Covered:
Online, Emerging Tech

  • With Airtasker (ASX:ART) having pre-released key line items such as GMV ($153.1m, +35% on pcp, +39% in Q4) and provided the Q4 (and FY21) cashflow statement, marginal financial information included a slightly higher takerate and Adj EBITDA beat.
  • ART has reiterated guidance provided in May at the time of the Zaarly acquisition for GMV >$200m and Revenue >$35m. This affirmation of guidance, despite lockdowns along the eastern seaboard, provides evidence of domestic marketplace momentum, comfort in the adaptability of the marketplace, and ability to bounceback upon easing of restrictions.
  • We increase our valuation/target price (login to view target price), maintaining the Add rating.

FY21 comes in ahead of expectations, largely pre-announced

ART has seen 35% GMV growth in FY21 (39% in Q4) despite the impact of Melbourne lockdowns in the 1H. This result was 6.5% ahead of prospectus and 2% ahead of May’s guidance midpoint.

ART has shown the ability to run the domestic business in a FCF positive manner (+$370k FCF, although benefitting from $2.4m contra media from SWM). With this dynamic likely to persist, and a balance sheet containing ~$46m cash, ART is well placed to attack the international opportunity that presents itself (UK, US combined TAM 11x domestic and growing)

Expected resiliency domestically paves the way for international push

ART has re-affirmed guidance provided in May despite the worsening lockdown situation (particularly relevant for a local services marketplace). ART remains confident in the marketplace’s ability to adapt the service offering, and the quick snapback (evident in Melbourne last year) post the easing of restrictions. ART continues to reference the ~12% reduction in GMV from June (pre-lockdowns) as being reflective of current trading.

FY22/23 will see a large step-up in spend, as ART commits ~$20m over the period (mainly in increased marketing) to begin their assault (in earnest) on these international markets. Having been in the UK for the past 3 years, we see this market as likely to become the initial driver of international traction, with Q4 GMV +232% on pcp (+93% QoQ) and continued strong weekly GMV growth evident.

ART continues to expand their product offering, with the recently launched listings product unlocking new service categories and now beginning to see material bookings increases (24% weekly compound growth rate) and 25k listings created to date. ART is likely to continue to innovate to increase penetration of the TAM.

Forecast and valuation update

We make minor changes to our forecasts, again lifting our expected marketing investment (mainly international but some domestic as well). We have reduced FY22 domestic GMV 1%, with a larger skew to the 2H than previously.

A 4% increase in the DCF portion of our valuation (slightly higher assumed LT international growth) is partially offset by a 1% reduction in our multiples valuation component, resulting in a 1.5% lift in valuation to $1.30.

Investment view

We remain attracted to Airtasker’s product fit with current consumer dynamics (move to e-commerce) attractive unit economics and large TAM potential, seeing signs of success internationally as a material re-rating catalyst.

Having proven an ability to derive significant topline growth with limited increased investment once the marketplace is established, we believe the market will continue to support ART during this period of heavy investment internationally.

Price catalysts

1Q22 update expected late Oct/early Nov. Indications of traction internationally, including launching in new cities and evidence of increased consumer and tasker awareness.

Risks

International expansion and the risk of investment in these markets not generating expected ROI or marketplace dynamics, competitive risk (especially relevant given the fledging nature of the market) potential legislative changes impacting ART.

Find out more

Download full research note

You can find further detailed analysis of company results this reporting season by browsing our reporting season tag, and view a full list of upcoming results on our Reporting Season Calendar.

If you would like access or more information, please contact your adviser or nearest Morgans office.

Request a call  Find local branch

Need access to our research?

You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team

Create trial account 

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

  • Print this page
  • Copy Link